Oncotelic Therapeutics
Why Robinhood?
You can watch OTLC and buy or sell other stocks, ETFs, and their options commission-free!About OTLC
Oncotelic Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of anti-vascular therapeutics for patients with cancer and sight-threatening eye diseases. It also develops OT-101 for various cancers and COVID-19, Artemisinin for COVID-19 and AI technologies for clinical development and manufacturing.
OTLC Key Statistics
Stock Snapshot
Oncotelic Therapeutics(OTLC) stock is priced at $0.02, giving the company a market capitalization of 7.59M. It carries a P/E multiple of 0.03.
During the trading session on 2026-10-18, Oncotelic Therapeutics(OTLC) shares reached a daily high of $0.02 and a low of $0.02. At a current price of $0.02, the stock is +10.7% higher than the low and still -7.8% under the high.
Trading volume for Oncotelic Therapeutics(OTLC) stock has reached 321.14K, versus its average volume of 448.69K.
Over the past 52 weeks, Oncotelic Therapeutics(OTLC) stock has traded between a high of $0.11 and a low of $0.02.
Over the past 52 weeks, Oncotelic Therapeutics(OTLC) stock has traded between a high of $0.11 and a low of $0.02.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.